Revolution Medicines
RVMD
RVMD
135 hedge funds and large institutions have $2.07B invested in Revolution Medicines in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.4% less ownership
Funds ownership: 100.76% → 99.36% (-1.4%)
5% less funds holding
Funds holding: 142 → 135 (-7)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
135
Holding in Top 10
12
Calls
$3.85M
Puts
$748K
Top Buyers
| 1 | +$63.3M | |
| 2 | +$35.6M | |
| 3 | +$23.8M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$19.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.8M |
Top Sellers
| 1 | -$47.6M | |
| 2 | -$47.6M | |
| 3 | -$19.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$12.7M |
| 5 |
Millennium Management
New York
|
-$9.36M |